Keizo Koya
CEO and President, Founder @SOLA Biosciences
Boston, MA, US
EMAILS
MOBILE NUMBERS
+91 *********19
Signup · Get unlimited contacts
WORK HISTORY
Jun 2016 — Present
CEO and President, Founder @SOLA Biosciences
View department →
SOLA Biosciences dedicates to develop gene-therapies for patients with neurodegenerative diseases by Engineered Targeting Chaperone Platform Technology (JUMP70) designed to harness the power of a patient’s own chaperones to repair specific disease-causing misfolding proteins.
SKILLS
CancerImmunologyOrganic ChemistryPharmacologyClinical DevelopmentGlpClinical TrialsR&DDrug DevelopmentCROMedicinal ChemistryLife SciencesPharmaceuticsLifesciencesGmpDrug DiscoveryAssay DevelopmentPharmaceutical IndustryCommercializationBiopharmaceuticalsBiochemistryProtein Chemistry
ABOUT KEIZO KOYA
With over 30 years of global pharmaceutical R&D and business strategy experience, I am…
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.